Pharmaceuticals— SEC Filing Activity & Signals
324 pharmaceuticals companies tracked above the $50M floor. In the last 90 days: 146 red 8-Ks, 0 insider cluster-buys, and 16 names running hot in the press. Sector 5-day move averages +5.91%.
324
Companies
146
Red 8-Ks · 90d
0
Insider clusters
16
🔥 Media-hot
WithinAllPharmaceuticals · 324Medical Devices · 134Biotechnology · 119Healthcare Services · 75Diagnostics & Tools · 27
All Pharmaceuticals companies
Open in Search →| # | Ticker | Company | Mkt cap | 1D | 5D | Volume | Heat | Signals |
|---|---|---|---|---|---|---|---|---|
| 1 | LLY | ELI LILLY & Co | $1010.3B | -2.5% | +8.3% | 3.7M | 🔥 | |
| 2 | JNJ | JOHNSON & JOHNSON | $579.8B | -1.8% | +6.2% | 8.5M | 🔥 | |
| 3 | ABBV | AbbVie Inc. | $402.4B | -1.1% | +7.2% | 7.0M | 🔥 | |
| 4 | MRK | Merck & Co., Inc. | $294.0B | -0.7% | +7.4% | 11.8M | ⚡ | |
| 5 | AZN | ASTRAZENECA PLC | $277.2B | -0.7% | +4.8% | 2.6M | 🔥 | |
| 6 | ABT | ABBOTT LABORATORIES | $153.6B | -2.1% | +0.2% | 10.0M | 🔥 | red 8-K |
| 7 | PFE | PFIZER INC | $149.4B | -1.2% | -2.6% | 60.0M | 🔥 | red 8-K |
| 8 | VRTX | VERTEX PHARMACEUTICALS INC / MA | $112.9B | -0.6% | +6.0% | 1.7M | 🔥 | red 8-K |
| 9 | REGN | REGENERON PHARMACEUTICALS, INC. | $64.2B | -1.3% | +0.9% | 821K | ⚡ | |
| 10 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | $37.8B | +2.6% | +4.5% | 1.4M | ⚡ | red 8-K |
| 11 | ZTS | Zoetis Inc. | $33.4B | -1.9% | -6.5% | 8.3M | 🔥 | red 8-K |
| 12 | RPRX | Royalty Pharma plc | $24.3B | -1.8% | +1.3% | 2.6M | ⚡ | |
| 13 | UTHR | UNITED THERAPEUTICS Corp | $23.2B | -0.6% | -0.5% | 551K | ⚡ | red 8-K |
| 14 | ROIV | Roivant Sciences Ltd. | $21.6B | +1.9% | +9.9% | 6.2M | — | |
| 15 | INSM | INSMED Inc | $21.2B | +1.8% | +4.4% | 3.4M | — | |
| 16 | VTRS | Viatris Inc | $19.2B | -2.2% | +0.8% | 10.5M | 🔥 | red 8-K |
| 17 | JAZZ | Jazz Pharmaceuticals plc | $14.5B | +1.4% | +4.7% | 1.0M | — | red 8-K |
| 18 | ASND | Ascendis Pharma A/S | $14.3B | +1.1% | +11.8% | 630K | — | |
| 19 | AXSM | Axsome Therapeutics, Inc. | $13.1B | +1.5% | +1.2% | 1.2M | — | red 8-K |
| 20 | BBIO | BridgeBio Pharma, Inc. | $13.1B | +3.4% | +8.5% | 3.4M | — | red 8-K |
| 21 | IONS | IONIS PHARMACEUTICALS INC | $12.1B | -1.7% | +4.3% | 2.4M | — | red 8-K |
| 22 | ELAN | Elanco Animal Health Inc | $12.1B | -0.5% | +6.2% | 3.5M | — | |
| 23 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | $11.1B | +1.8% | +4.6% | 393K | — | red 8-K |
| 24 | RDY | DR REDDYS LABORATORIES LTD | $11.1B | -2.5% | +1.3% | 3.4M | — | |
| 25 | SMMT | Summit Therapeutics Inc. | $10.9B | +1.8% | +2.3% | 5.3M | — | |
| 26 | BMRN | BIOMARIN PHARMACEUTICAL INC | $10.8B | -0.8% | +1.3% | 1.7M | — | red 8-K |
| 27 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | $10.5B | +1.3% | +2.0% | 2.7M | — | red 8-K |
| 28 | NUVL | Nuvalent, Inc. | $9.8B | -0.0% | +0.1% | 1.7M | 🔥 | |
| 29 | CYTK | CYTOKINETICS INC | $9.5B | -2.4% | +6.5% | 2.4M | — | |
| 30 | RGC | Regencell Bioscience Holdings Ltd | $9.3B | -1.6% | -45.0% | 448K | ⚡ | |
| 31 | CORT | CORCEPT THERAPEUTICS INC | $8.9B | -1.1% | +8.9% | 739K | — | red 8-K |
| 32 | TGTX | TG THERAPEUTICS, INC. | $7.6B | -1.4% | +1.9% | 2.6M | ⚡ | |
| 33 | PRAX | Praxis Precision Medicines, Inc. | $7.4B | -4.5% | +9.6% | 744K | ⚡ | |
| 34 | ALKS | Alkermes plc. | $7.4B | -0.3% | +9.0% | 3.0M | — | red 8-K |
| 35 | PTGX | Protagonist Therapeutics, Inc | $7.1B | +0.8% | +3.0% | 561K | — | red 8-K |
| 36 | SYRE | Spyre Therapeutics, Inc. | $7.0B | -1.5% | -8.5% | 1.5M | — | red 8-K |
| 37 | LEGN | Legend Biotech Corp | $6.7B | -1.7% | -1.4% | 1.0M | ⚡ | |
| 38 | LQDA | Liquidia Corp | $6.3B | +6.1% | +7.7% | 1.7M | — | |
| 39 | PTCT | PTC THERAPEUTICS, INC. | $6.2B | 0.0% | -0.7% | 2.4M | — | red 8-K |
| 40 | CNTA | Centessa Pharmaceuticals plc | $6.1B | +0.8% | +1.9% | 11.3M | — | red 8-K |
| 41 | RYTM | RHYTHM PHARMACEUTICALS, INC. | $6.1B | +0.9% | +4.6% | 991K | ⚡ | red 8-K |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | $6.1B | -4.8% | +5.4% | 1.2M | — | |
| 43 | COGT | Cogent Biosciences, Inc. | $5.7B | -0.1% | +6.6% | 5.6M | — | |
| 44 | BLTE | BELITE BIO, INC | $5.5B | -0.4% | +6.1% | 225K | — | |
| 45 | AMRX | Amneal Pharmaceuticals, Inc. | $5.2B | +0.1% | +3.9% | 2.3M | — | |
| 46 | TNGX | Tango Therapeutics, Inc. | $5.0B | -4.0% | +10.1% | 4.8M | ⚡ | red 8-K |
| 47 | XENE | Xenon Pharmaceuticals Inc. | $5.0B | +0.4% | +10.5% | 1.3M | — | red 8-K |
| 48 | TVTX | Travere Therapeutics, Inc. | $4.8B | -2.6% | +1.5% | 2.4M | ⚡ | red 8-K |
| 49 | INDV | Indivior Pharmaceuticals, Inc. | $4.5B | -0.6% | +2.7% | 1.6M | — | red 8-K |
| 50 | DNTH | Dianthus Therapeutics, Inc. /DE/ | $4.5B | +1.9% | +11.4% | 1.4M | ⚡ |